Back to search

France· FR:68759769

EZETIMIBE/SIMVASTATINE ZYDUS 10 mg/20 mg, comprimé

A medicinal product containing simvastatine + ézétimibe, registered in France by ZYDUS FRANCE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedEZETIMIBE/SIMVASTATINE ZYDUS 10 mg/20…ATC—REGISTER NO.FR:68759769PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SIMVASTATINE + ÉZÉTIMIBE
Manufacturer
ZYDUS FRANCE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930158609
    plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 30 comprimé(s)
    EUR 13.21
  • cip13
    3400930158623
    plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 90 comprimé(s)
    EUR 37.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Simvastatine + ézétimibe in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatine + ézétimibe products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Ezesim, Ezetimib/Simvastatin Accord
  • Belgium · Ezetimib/Simvastatin Ab, Ezetimibe/Simvastatin Krka
  • Cyprus · Ezetimibe/Simvastatin Accord, Inegy
  • Czechia · Ezetimibe/Simvastatin Teva Cr, Glezisim
  • Germany · Ezesimin, Ezetimib Simvastatin Zentiva
  • Denmark · Ezetimib/Simvastatin Demo, Ezetimib/Simvastatin Hexal
  • Spain · Ezetimiba/Simvastatina Alter, Ezetimiba/Simvastatina Aurovitas
  • United Kingdom (Northern Ireland) · Ezetimibe/Simvastatin Accord Healthcare, Ezetimibe/Simvastatin Ascend Laboratories
  • Greece · Cildar Plus, Ezetimib/Simvastatin Mylan
  • Croatia · Inegy, Vasitimb
  • Hungary · Inegy
  • Ireland · Ezetimibe/Simvastatin Clonmel, Ezetimibe/Simvastatin Krka
  • Iceland · Ezetimib/Simvastatin Krka, Inegy
  • Italy · Ezetimibe E Simvastatina Accord, Ezetimibe E Simvastatina Almus
  • Luxembourg · Ezetimib/Simvastatin Ratiopharm®, Ezetimibe/Simvastatine Eg
  • Netherlands · Ezetimibe/Simvastatin Aurobindo, Ezetimibe/Simvastatine Cf
  • Norway · Ezetimib/Simvastatin Glenmark, Ezetimib/Simvastatin Krka
  • Portugal · Inegy, Sinvastatina + Ezetimiba Alter
  • Sweden · Ezetimib/Simvastatin Krka, Ezetimibe/Simvastatin Accord
  • Slovenia · Inegy, Vasitimb
  • Slovakia · Cornusan, Ezetimib/Simvastatín Teva B.V.

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/92a4cd32-7b98-4752-847c-faa20c2cd455
GET /v1/drugs/92a4cd32-7b98-4752-847c-faa20c2cd455?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68759769",
  "date_amm": "2018-09-21",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SIMVASTATINE + ÉZÉTIMIBE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about simvastatine + ézétimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.